Eaton Vance Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $129M | Buy |
|
|||||
|
2022
Q2 | $128M | Buy |
|
|||||
|
2022
Q1 | $117M | Buy |
|
|||||
|
2021
Q4 | $122M | Sell |
|
|||||
|
2021
Q3 | $116M | Buy |
|
|||||
|
2021
Q2 | $114M | Buy |
|
|||||
|
2021
Q1 | $107M | Buy |
|
|||||
|
2020
Q4 | $95.5M | Sell |
|
|||||
|
2020
Q3 | $106M | Buy |
|
|||||
|
2020
Q2 | $127M | Sell |
|
|||||
|
2020
Q1 | $184M | Sell |
|
|||||
|
2019
Q4 | $223M | Sell |
|
|||||
|
2019
Q3 | $228M | Sell |
|
|||||
|
2019
Q2 | $268M | Buy |
|
|||||
|
2019
Q1 | $245M | Buy |
|
|||||
|
2018
Q4 | $223M | Sell |
|
|||||
|
2018
Q3 | $291M | Buy |
|
|||||
|
2018
Q2 | $259M | Sell |
|
|||||
|
2018
Q1 | $593M | Buy |
|
|||||
|
2017
Q4 | $309M | Sell |
|
|||||
|
2017
Q3 | $359M | Buy |
|
|||||
|
2017
Q2 | $182M | Sell |
|
|||||
|
2017
Q1 | $189M | Sell |
|
|||||
|
2016
Q4 | $202M | Sell |
|
|||||
|
2016
Q3 | $306M | Buy |
|
|||||
|
2016
Q2 | $317M | Buy |
|
|||||
|
2016
Q1 | $302M | Sell |
|
|||||
|
2015
Q4 | $352M | Sell |
|
|||||
|
2015
Q3 | $474M | Buy |
|
|||||
|
2015
Q2 | $308M | Buy |
|
|||||
|
2015
Q1 | $256M | Sell |
|
|||||
|
2014
Q4 | $321M | Sell |
|
|||||
|
2014
Q3 | $438M | Sell |
|
|||||
|
2014
Q2 | $387M | Sell |
|
|||||
|
2014
Q1 | $454M | Buy |
|
|||||
|
2013
Q4 | $462M | Sell |
|
|||||
|
2013
Q3 | $403M | Sell |
|
|||||
|
2013
Q2 | $348M | Buy |
|